AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$612M
This Quarter Return
+4.38%
1 Year Return
+36.74%
3 Year Return
+173.74%
5 Year Return
+333.08%
10 Year Return
+727.51%
AUM
$574M
AUM Growth
+$574M
(+12%)
Cap. Flow
+$36.4M
Cap. Flow
% of AUM
6.34%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
171
New
44
Increased
34
Reduced
30
Closed
43
Top Buys
| 1 |
Centene
CNC
|
$19.4M |
| 2 |
Oracle
ORCL
|
$12.8M |
| 3 |
Zimmer Biomet
ZBH
|
$12.4M |
| 4 |
NGD
New Gold Inc
NGD
|
$11M |
| 5 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$10.3M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$18.4M |
| 2 |
SSNI
Silver Spring Networks, Inc.
SSNI
|
$16.5M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$8.73M |
| 4 |
BRG
Bluerock Residential Growth REIT, Inc.
BRG
|
$8.05M |
| 5 |
MarketAxess Holdings
MKTX
|
$7.04M |
Sector Composition
| 1 | Healthcare | 22.66% |
| 2 | Technology | 17.5% |
| 3 | Materials | 9.95% |
| 4 | Utilities | 8.64% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cigna
CI
$80.3B
| $654K | 0.09% | 3,500 +1,000 | +40% | +$187K |
|
77
BioMarin Pharmaceuticals
BMRN
$11.2B
| $651K | 0.09% | 7,000 | – | – |
|
78
Darling Ingredients
DAR
$5.37B
| $613K | 0.08% | +35,000 | New | +$613K |
|
79
Intuit
INTU
$186B
| $569K | 0.08% | +4,000 | New | +$569K |
|
|
CBAY
80
DELISTED
Cymabay Therapeutics
CBAY
| $566K | 0.08% | 70,210 +20,000 | +40% | +$161K |
|
81
IES Holdings
IESC
$6.94B
| $519K | 0.07% | +30,000 | New | +$519K |
|
82
Aclaris Therapeutics
ACRS
$209M
| $516K | 0.07% | 20,000 +5,000 | +33% | +$129K |
|
83
Take-Two Interactive
TTWO
$43B
| $511K | 0.07% | 5,000 -10,000 | -67% | -$1.02M |
|
|
TWTR
84
DELISTED
Twitter, Inc.
TWTR
| $506K | 0.07% | 30,000 +10,000 | +50% | +$169K |
|
85
Flex
FLEX
$20.1B
| $464K | 0.06% | +28,000 | New | +$464K |
|
86
AbbVie
ABBV
$372B
| $444K | 0.06% | 5,000 -2,500 | -33% | -$222K |
|
87
8x8 Inc
EGHT
$270M
| $405K | 0.05% | +30,000 | New | +$405K |
|
|
BIVV
88
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $399K | 0.05% | +7,000 | New | +$399K |
|
89
LSB Industries
LXU
$599M
| $397K | 0.05% | +50,000 | New | +$397K |
|
90
Salesforce
CRM
$245B
| $374K | 0.05% | 4,000 -5,000 | -56% | -$468K |
|
91
Quanta Services
PWR
$56.3B
| $374K | 0.05% | +10,000 | New | +$374K |
|
|
ALDR
92
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $368K | 0.05% | +30,000 | New | +$368K |
|
|
XLNX
93
DELISTED
Xilinx Inc
XLNX
| $354K | 0.05% | +5,000 | New | +$354K |
|
94
AtriCure
ATRC
$1.84B
| $336K | 0.04% | 15,000 | – | – |
|
95
Regenxbio
RGNX
$451M
| $330K | 0.04% | 10,000 | – | – |
|
96
Merck
MRK
$210B
| $320K | 0.04% | +5,000 | New | +$320K |
|
|
SLCA
97
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $311K | 0.04% | +10,000 | New | +$311K |
|
|
NVTR
98
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $293K | 0.04% | 22,095 | – | – |
|
99
Pegasystems
PEGA
$9.27B
| $288K | 0.04% | +5,000 | New | +$288K |
|
100
Aldeyra Therapeutics
ALDX
$351M
| $285K | 0.04% | 39,552 +25,000 | +172% | +$180K |
|